Drug Database
Back to search

Canada· CA-DIN-02481367

VELTASSA

A patiromer calcium product containing patiromer (patiromer sorbitex calcium), registered in Canada by VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD. The same ATC class is registered in 12 of our 19 countries.

ATC V03AE09

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedVELTASSAATCV03AE09REGISTER NO.CA-DIN-02481367PACKS LISTED0CHECKEDOctober 1, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about patiromer (patiromer sorbitex calcium)Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Patiromer calcium is registered in 12 of 19 countries.

Countries holding a registration under ATC V03AE09 (patiromer calcium), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 7 of them publish a price we can compare per daily dose
Search patiromer calcium products by name

Patiromer calcium · ATC V03AE09

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of patiromer calcium costs, country by country.

Normalised to the WHO defined daily dose (8.4 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Patiromer calcium · price per daily dose (8.4 g)

USD · FX 28 Sept 2026

  • CH Switzerland$8.39
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
PATIROMER (PATIROMER SORBITEX CALCIUM)
Manufacturer
VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD
Country
Canada (CA)
ATC code
V03AE09
ATC class
Patiromer calcium
Defined daily dose
8.4 g, O
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

69 interactions on record for patiromer calcium.

Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check patiromer calcium against other medicinesHow interaction checks work

Patiromer calcium · interactions on record

69 records

  • 12 severe
  • 57 moderate

Most severe, free to view

  • Magnesium carbonateA02AA01severe
  • Magnesium oxideA02AA02severe
  • Magnesium hydroxideA02AA04severe
  • Kombinationen von AluminiumsalzenA02AB10severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Patiromer calcium in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All patiromer calcium products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Veltassa
  • Liechtenstein · Veltassa
  • Norway · Veltassa

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dcf97d00-1c10-4307-824f-2029ed7096e8
GET /v1/drugs/dcf97d00-1c10-4307-824f-2029ed7096e8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02481367",
  "form": "POWDER FOR SUSPENSION",
  "class": "Human",
  "routes": [
    "ORAL"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "V03AE09",
  "schedule": [
    "Prescription"
  ],
  "drug_code": "97185",
  "strengths": [
    "16.8 G"
  ],
  "ahfs_class": null,
  "substances": [
    "PATIROMER (PATIROMER SORBITEX CALCIUM)"
  ],
  "product_categorization": null
}
API referenceMCP serverPlans

See everything about patiromer calcium.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console